Answers are grounded in this paper and cite their sources.
Abstract As a means of addressing medical problems, rare earth nano-oxides are gaining prominence. For the first time, Silver (Ag) and Polyvinylpyrrolidone (PVP) capped Yttrium oxide (Y₂O₃) ternary nanocomposites (Ag/PVP @ Y₂O₃ ) were synthesised using a hydrothermal route. In fixed amounts of PVP and Y₂O₃, different concentrations of Ag (0.5% and 1.5%) were utilised. XRD, FTIR, HRTEM, XPS, UV-VIS, and PL spectroscopy were used to systematically characterise the as-synthesised NCs. By employing the X-ray diffractogram (XRD) technique, the Y₂O₃ crystals have a rod-shaped cubic structure, with doping causing them to increase from 41 nm to 52 nm in size. Peaks at 563 cm⁻ ¹ and 559 cm⁻ ¹ in the FTIR spectrum demonstrated the presence of Y₂O₃ and indicated the formation of the Y-O bond. The charge transfer efficiency of the synthesised nanocomposites was shown by PL spectra. XPS analysis validated the existence of constituent elements (Y₂O₃) and dopants (Ag, and PVP), as long as only a single element of zero valence silver was present in the system. The Ag/PVP @ Y₂O₃ NPs showed the most remarkable cytotoxicity with the IC₅₀ value of 32.56 µg/mL against MCF-7 cells which could be a promising agent in the field of nanomedicine.
No takes yet. Share an insight, caveat, or question.
Myvizhi et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: